Innate Immunotherapeutics, whose largest shareholder is Buffalo-area Rep. Chris Collins, received FDA approval to begin U.S. trials of its drug for treating advanced multiple sclerosis.
Armed with strict guidelines and motivated by sheer urgency, a specialized team of nurses makes the rounds, seeking to thwart the No. 1 killer in U.S. hospitals.
A Washington state woman didn’t find out for months that she was likely infected with the virus that can cause serious birth defects. Clinic officials say they’ll do better.
A small number of medical practices have been moving to “direct primary care,” in which patients pay a monthly retainer for unlimited services. But the collapse of Qliance in Seattle may portend problems with the business model.
A bill pending in the state legislature could make the Golden State the first in the U.S. to open establishments where intravenous drug users can shoot up under medical supervision. Proponents say that would save lives.
No one knows what the final Senate bill will look like — not even those writing it. But here are some safe, educated guesses.
Documents examined by Kaiser Health News shed light on the workings of the Trump administration’s “Drug Pricing and Innovation Working Group.”
Critics point to the state’s aggressive eligibility checks as an example of what can go wrong when states have flexibility and add a reason to worry about GOP efforts to overhaul the program.
An analysis by the Environmental Defense Fund found lead more commonly in baby food than in other food. Lead was often present in fruit juice, though the research did not measure the level of contamination.
Almost 30 percent of patients leaving the hospital don’t want home health care services, which often leads to readmissions and other health issues.
The U.S. government has been struggling to balance a surge in applicants for disability benefits with shrinking funds. An updated application process could make getting benefits even harder.
The Seattle case, the first to reach trial in the U.S., offers possible glimpse into fate of some two dozen lawsuits against manufacturing giant Olympus, accused of failing to address scope contamination linked to numerous deaths. The company faults poor hospital cleaning practices.
The Senate’s secret deliberation on the health bill overhaul is part of a long, slow slide away from transparency. And I’m a witness.
This year’s American Diabetes Association scientific meeting came with a hefty price — a policy of no photography and limits on social media. That did not go over well on Twitter.
The North Carolina Harm Reduction Coalition has advanced a local shift from a tough-on-drugs approach to harm-reduction philosophy. Other red states signal they may follow suit.
In Pennsylvania alone, 124,000 people received drug or alcohol addiction treatment through Medicaid. Republicans in Congress want to cut Medicaid by as much as $800 billion over the next decade, leaving people in recovery wondering what will happen to their treatment.
States are not doing enough to help elderly and disabled Medicaid enrollees receive services in homes and community locations instead of in nursing homes, where care is more expensive, AARP report says.
Lo primero que hizo María Ríos cuando nació su beba es chequear el tamaño de su cabeza. Fue entonces cuando supo que sus miedos se habían hecho realidad: la niña había nacido con microcefalia, una consecuencia del zika.
With lots of questions about the 2018 insurance market still in play, someone who is between jobs might want to stick with their job-based insurance at least until the outlines of the health law’s marketplaces are clear in the fall.
So far, 72 affected babies have been born in the continental U.S. One young mother, infected in Mexico last year, and her infant face an uncertain future in rural Washington.